JENNIFER CHOUCHANI: Open Payments
NPI 1710285689 · DEPEW, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$678 in 37 payments from 14 companies in 2025. Trend: 2023 $710 · 2024 $568 · 2025 $678
Food & beverage: $678
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 9 | $145 |
| Corcept Therapeutics | 4 | $67 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $66 |
| GlaxoSmithKline, LLC. | 4 | $64 |
| Exact Sciences Corporation | 3 | $60 |
| Abbott Laboratories | 2 | $50 |
| Lilly USA, LLC | 3 | $49 |
| ABBVIE INC. | 2 | $45 |
| PFIZER INC. | 2 | $36 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $22 |
Products named: OTEZLA, JARDIANCE, Korlym, The Cologuard Plus Collection Kit, FREESTYLE LIBRE 3, TRELEGY ELLIPTA, SYNTHROID, XIFAXAN.
Industry payments across NY — which companies pay providers there.
